Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

D-THYROXINE SODIUM SALT

Base Information Edit
  • Chemical Name:D-THYROXINE SODIUM SALT
  • CAS No.:137-53-1
  • Molecular Formula:C15H11 I4 N O4 . Na
  • Molecular Weight:798.85
  • Hs Code.:
  • Mol file:137-53-1.mol
D-THYROXINE SODIUM SALT

Synonyms:D-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt (9CI); Thyroxine,monosodium salt, D- (8CI); Biotirmone; Choloxin; D-Thyroxine monosodium salt;D-Thyroxine sodium; D-Thyroxine sodium salt; Debetrol; Dethyrona; Detyroxin;Dextroid; Dextrothyroxine sodium; Dextroxin; Dynothel; Eulipos; Lisolipin;Nadrothyron D; Sodium D-3,3',5,5'-tetraiodothyronine; Sodium D-thyroxine;Sodium d-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]alanine; Sodiumdextrothyroxine; Travenon

Suppliers and Price of D-THYROXINE SODIUM SALT
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • D-ThyroxineSodiumSalt
  • 10mg
  • $ 45.00
  • American Custom Chemicals Corporation
  • DEXTROTHYROXINE SODIUM 95.00%
  • 5MG
  • $ 495.59
Total 19 raw suppliers
Chemical Property of D-THYROXINE SODIUM SALT Edit
Chemical Property:
  • Vapor Pressure:4.02E-14mmHg at 25°C 
  • Boiling Point:576.3°Cat760mmHg 
  • Flash Point:302.3°C 
  • PSA:95.61000 
  • Density:g/cm3 
  • LogP:3.92290 
Purity/Quality:

95% 98% 99% *data from raw suppliers

D-ThyroxineSodiumSalt *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Uses D-Thyroxine sodium salt (CAS# 137-53-1) is a persistent and bioaccumulative pharmaceutical, and the sodium salt form of D-Thyroxine (T425605), a hormone involved in the maintenance of metabolic homeostasis. Antihyperlipidemic.
  • Therapeutic Function Thyroid hormone, Anticholesteremic
  • Clinical Use D-Thyroxine monosodium salt potentiates the action of anticoagulants suchas warfarin or dicumarol; thus, the dosage of the anticoagulantsused concurrently should be reduced by one third andthen, if necessary, further modified to maintain the prothrombintime within the desired limits.
Post RFQ for Price